Italy-based biotech startup specializing in the creation of products and applications based on exosomes
ExoLab Italy has raised €5.0M across 1 funding round from 4 investors, most recently a Series A round in Feb 2025. Based in L’Aquila, Italy; active in Foodtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-18 | Series A | €5.0M |
| CDP Venture Capital,dsm-firmenich Ventures,Linfa Fund,Maia Ventures |
| View deal → |
